In a report released today, Peter Lawson from Barclays maintained a Hold rating on Blueprint Medicines (BPMC – Research Report), with a price ...

The medicines chain is no longer transparent or readily traceable. With rising demand and medicine shortages comes unscrupulous behavior. Consumer demand for medicines is simultaneously increasing ...

Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Medicines may be processed, packaged, sold, and resold multiple times before reaching consumers. For regulators, it can be difficult to ensure the safety of drugs before they hit pharmacy shelves.

If you’re desperate to build your own castle but need some inspiration for its design, these Minecraft castle blueprints, tutorials, and ideas are simple to download, easy to follow, and perfect ...

An illustration of a magnifying glass. An illustration of a magnifying glass.

A final blueprint for where 22,500 new homes will be built and thousands of jobs created in South Gloucestershire over the next 15 years has been published. The Local Plan sets out how housing ...

Ahmedabad: The Kumbh isn't just a religious gathering but a blueprint for sustainable civilization, a testament to cultural authenticity and a living example of tradition adapting to modernity ...

15 analysts have expressed a variety of opinions on Blueprint Medicines (NASDAQ:BPMC) over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table below ...